Form D · Pharmaceuticals

BlossomHill Therapeutics, Inc.

San Diego, CA · CIK 0001839970

Offering snapshot reported Dec 10, 2025 · SEC filing

Reported sold
$84.2M
Offering amount: $84.2M
Investors reported
47
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 25, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 10, 2025Initial$84,152,909No comparison47SEC filing
Jan 2, 2024Initial$88,649,917No comparison44SEC filing
Mar 1, 2021Initial$70,999,993No comparison27SEC filing
Jan 11, 2021Initial$2,000,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-566357

Source: Form D, filed Dec 10, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sundeep Agrawal Director
Bihua Chen Director
Carl Gordon Director
Jingrong Jean Cui Director, Executive
George Lee Director
Yishan Li Director, Executive
Hongbo Lu Director
Timothy Stubbs Director
Li Peter Yishan Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
10255 Science Center Drive Suite 200
San Diego, CA, 92121
Phone: 858-732-3880